Live Breaking News & Updates on Paragon Partners Gmbh

Stay updated with breaking news from Paragon partners gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |APONTIS PHARMA AG Announcements | APONTIS PHARMA AG: APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share


DGAP-News: APONTIS PHARMA AG
/ Key word(s): IPO
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
06.05.2021 / 20:09
The issuer is solely responsible for the content of this announcement.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
Total placement volume of EUR 101 million including over-allotment and upsize options ....

United States , United Kingdom , Sven Pauly , Sara Pinto , Karlheinz Gast , Frankfurt Stock Exchange Subscription Functionality , United Kingdom Financial Services , Securities Of The Company , Financial Services , Frankfurt Stock Exchange Scale , Frankfurt Stock Exchange , Single Pills , Paragon Partners , Single Pill , Paragon Partners Gmbh , Partners Gmbh , Apontis Pharma , Markets Act , Financial Promotion , Relevant Persons , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஸ்வெந் பாலீ , சாரா பிண்டோ , ஒன்றுபட்டது கிஂக்டம் நிதி சேவைகள் , பத்திரங்கள் ஆஃப் தி நிறுவனம் ,

APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share


Search jobs
29-Apr-2021
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share
DGAP-News: APONTIS PHARMA AG
/ Key word(s): IPO
29.04.2021 / 08:30
The issuer is solely responsible for the content of this announcement.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share ....

United States , United Kingdom , Sven Pauly , Sara Pinto , Karlheinz Gast , Hauck Aufh , German Federal Financial Supervisory Authority Bafin , Munich Stock Exchange , Dusseldorf Stock Exchange , United Kingdom Financial Services , Distribution Services , Virtx Exchange , Paragon Fund Ii Gmbh Co , Tradegate Exchange , Hanover Stock Exchange , Stuttgart Stock Exchange , Eurocac Stock Exchange , Mm Warburg Co , European Parliament , Chix Exchange , Frankfurt Stock Exchange Scale , Financial Services , Securities Of The Company , Frankfurt Stock Exchange , Mm Warburg , German Federal Financial Supervisory Authority Bundesanstalt ,